Naloxona Kern Pharma

Medicinal product

(Invented) name

Naloxona Kern Pharma

Active substance (s)

Naloksono hidrochloridas

Strength

0,4 mg/ml

Pharmaceutical form

injekcinis ar infuzinis tirpalas

Route (s) of administration

leisti į veną, leisti į raumenis, leisti po oda

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

V03AB15, Naloxone

Marketing authorisation holder

UAB Lex ano, Lietuva

Date of authorisation

2020-09-09

Date of renewal

Documents

1389_Naloxona Kern Pharma_0,4mg-ml_inf_inf_tirp_PZPL_2020-09-09.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml tirpalo yra	1 ml
Naloksono hidrochloridas	0,4 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
104981	91083	1091083	ampulė	1 ml N10	ASPĮ	Receptinis	LT/L/20/1389/001	Netiekiama	2025-06-11	-	No	-	-	Download

Stadijos

Data	Stadija
2020-09-09	Registruotas